Form 8-K - Current report:
SEC Accession No. 0001104659-24-122860
Filing Date
2024-11-26
Accepted
2024-11-26 08:30:19
Documents
13
Period of Report
2024-11-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2429370d3_8k.htm   iXBRL 8-K 26740
  Complete submission text file 0001104659-24-122860.txt   199821

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA repl-20241125.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20241125_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20241125_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2429370d3_8k_htm.xml XML 3683
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 241498256
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)